Skip to content

Clinical trials

Completed Multiple Myeloma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: Japan Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20101
20116
20125
20133
201410
20156
20168
20177
20184
20194
20201
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene12
Janssen Pharmaceutical K.K.7
Amgen6
Bristol-Myers Squibb6
Janssen Research & Development, LLC6
Novartis Pharmaceuticals5
Sanofi5
Takeda5
Pfizer4
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma65
Recurrence10
Lymphoma5
Arrhythmias, Cardiac3
Heart Failure3
Hypersensitivity3
Infections3
Lung Diseases, Interstitial3
Neoplasms3
Neoplasms, Plasma Cell3

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.